These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8618294)

  • 1. Interstitial radiofrequency therapy of the prostate: results of a pilot study.
    Mostafid AH; Harrison NW; Dawkins GP; Fletcher MS
    J Urol; 1996 Jun; 155(6):1946-8; discussion 1948-9. PubMed ID: 8618294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency thermal ablation of the prostate: the TUNA technique.
    Heaton JP
    Tech Urol; 1995; 1(1):3-10. PubMed ID: 9118364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial laser coagulation of the prostate for management of acute urinary retention.
    Nishizawa K; Kobayashi T; Watanabe J; Ogura K
    J Urol; 2003 Sep; 170(3):879-82. PubMed ID: 12913721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
    Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
    Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up.
    Terada N; Arai Y; Okubo K; Ichioka K; Matsui Y; Yoshimura K; Terai A
    Int J Urol; 2004 Nov; 11(11):978-82. PubMed ID: 15509201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral electrovaporization vs transurethral resection for symptomatic prostatic obstruction: a meta-analysis.
    Poulakis V; Dahm P; Witzsch U; Sutton AJ; Becht E
    BJU Int; 2004 Jul; 94(1):89-95. PubMed ID: 15217438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral vaportrode electrovaporization of the prostate: physical principles, technique, and results.
    Narayan P; Tewari A; Garzotto M; Parramore HW; Schalow E; Starling J; Jones T
    Urology; 1996 Apr; 47(4):505-10. PubMed ID: 8638358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holmium laser prostatic resection for patients presenting with acute urinary retention.
    Anderson CB; Helfand BT; McVary KT
    BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral needle ablation of the prostate: report of initial United States clinical trial.
    Issa MM
    J Urol; 1996 Aug; 156(2 Pt 1):413-9. PubMed ID: 8683692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
    Roehrborn CG
    BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Kongkanand A; Chodchoy V; Lojanapiwat B; Pumpaisanchai S; Ratana-Olarn K; Sae-Tang P; Taweemonkongsap T
    J Med Assoc Thai; 2009 Jul; 92(7):969-78. PubMed ID: 19626818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
    Magoha GA
    East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
    BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.